Randmized Controlled Trial for validity and safety to effect of high hemoglobin(Hb) level on kidney function post kidney transplant recipients.
Not Applicable
- Conditions
- Chronic kidney disease after kidney transplantation
- Registration Number
- JPRN-UMIN000009594
- Lead Sponsor
- agoya Daini Red Cross Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1.Urine protein more than 1g/day 2.Deterionation of kidney function within the preceding 3 months 3.History of acute rejection within 3 months 4.Uncontrolled hypertension(systolic blood pressure>140,diastolic blood pressure>100) 5.Active or uncontrolled infection 6.Prior diagnosis of malignancy 7.Iron deficiency anemia 8.Hemorrhage diathesis 9.Hb<10g/dl with ESA 10.Pregnancy or lactation 11.History of myocardial infarctioin or angina pectoris 12.History of cerebral infarction with any symptom 13.Hypersensitivity reactions to ESA
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Difference between Hb normal group and Hb subnormal group in rate of decline in kidney function for 5 years
- Secondary Outcome Measures
Name Time Method